Ελλάδα: η χώρα που ξέρουν όλοι καλύτερα από σένα (που έχεις πτυχίο, μεταπτυχιακό και διδακτορικό στη φαρμακευτική) ότι η μωβ εισπνοή (βλ. Seretide 250/50) είναι η καλή, ενώ η καφέ (βλ. Rolenium 250/50) δεν κάνει τίποτα🤨
By the way είναι ακριβώς το ίδιο 🤫
Prof. Grigoris Zoidis et al. summarized the key steps of the #HBV life cycle, examines the currently approved anti-HBV drugs, and analyzes novel HBV treatment regimens.
#HepatitisB
📃Read Full-Text Via:
https://t.co/OPtFtFm2ei
There’s so much behind this pic…amazing people, places and experiences, as well as anxiety, difficulties and sacrifices. It was a life and mind changing journey, but now I can say ‘‘PhD 100% is done’’
UNVEILING OF THE 1st EFMC PHOTO COLLAGE🎉
EFMC more that anything is a community, and we want to celebrate all those who contributed to its success over the past 50 years!
The collage can only capture a small part of our members and activities, but we hope you will like it!
Social distancing works.
The London School of Hygiene and Tropical Medicine estimate that before the lockdown one positive person would infect 2.6 other people.
Now it's just 0.62.
This means the virus is cornered - it has nowhere to go and will burn out. Good news.
I’m glad that my church will not be “packed by Easter.” In fact, we’ve already decided we will be empty on Easter. Why? Because we love our neighbors, and that is the whole point.
Medicinal chemists are interested in the main protease of #SARSCoV2, a potential pathway to #antiviral treatments for the virus that causes #COVID19. https://t.co/D0O3tQDRIj
People are asking whether patients with COVID19 who don’t have symptoms, e.g. cough or even just fever, can transmit the disease to others. The answer seems to be yes. Alas, this is not good news, but we can still take rational steps. Let’s talk about this. #QuarantineLoophole 1/
Remdesivir was initially developed for Ebola and made it to Phase 3 clinical trial. That means that we know its relatively safe to use in humans. At that point, other therapeutics and vaccines took over, and it wasn’t developed further.
At this point, you’ve probably heard a ton about chloroquine and hydroxychloroquine and how they may be effective in treating COVID-19. I wanted to tell you about a different molecule that’s getting less attention but may have good potential – Remdesivir.
“aerosol and fomite transmission of SARS-CoV-2 is plausible, since the virus can re- main viable and infectious in aerosols for hours and on surfaces up to days” @NEJM#COVID19#coronavirus#SARSCoV2